Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 5011 AL 5025

Cognitive impairment in progressive supranuclear palsy is associated with tau burden

Koga S, Parks A, Kasanuki K, Sanchez-Contreras M, Baker MC, Josephs KA, Ahlskog JE, Uitti RJ, Graff-Radford N, van Gerpen JA, Wszolek ZK, Rademakers R, Dickson DW.

Mov Disord. 2017 Dec;32(12):1772-1779. doi: 10.1002/mds.27198. Epub 2017 Oct 30.

Current trends in etiology, prognosis and therapeutic aspects of Parkinson's disease: a review

Jagadeesan AJ, Murugesan R, Vimala Devi S, Meera M, Madhumala G, Vishwanathan Padmaja M, Ramesh A, Banerjee A, Sushmitha S, Khokhlov AN, Marotta F, Pathak S.

Acta Biomed. 2017 Oct 23;88(3):249-262. doi: 10.23750/abm.v88i3.6063.

The cerebral basis of Parkinsonian tremor: A network perspective

Helmich RC.

Mov Disord. 2018 Feb;33(2):219-231. doi: 10.1002/mds.27224. Epub 2017 Nov 9.

Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature

Schneider SA, Alcalay RN.

Mov Disord. 2017 Nov;32(11):1504-1523. doi: 10.1002/mds.27193.

Early versus Late Application of Subthalamic deep brain Stimulation to Parkinson's disease patients with motor complications (ELASS): protocol of a multicentre, prospective and observational study

Jiang L, Poon WS, Moro E, Xian W, Yang C, Zhu XL, Gu J, Cai X, Liu J, Mok V, Liu Y, Xu S, Guo Q, Chen W, Chen L.

BMJ Open. 2017 Nov 16;7(11):e018610. doi: 10.1136/bmjopen-2017-018610.

Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age

Dafsari HS, Reker P, Stalinski L, Silverdale M, Rizos A, Ashkan K, Barbe MT, Fink GR, Evans J, Steffen J, Samuel M, Dembek TA, Visser-Vandewalle V, Antonini A, Ray-Chaudhuri K, Martinez-Martin P, Timmermann L; EUROPAR and the IPMDS (International Parkinson's and Movement Disorders Society) Non-Motor Parkinson's Disease Study Group.

Mov Disord. 2018 Jan;33(1):99-107. doi: 10.1002/mds.27222. Epub 2017 Nov 18.

Parkinson's disease: experimental models and reality

Jiang P, Dickson DW.

Acta Neuropathol. 2018 Jan;135(1):13-32. doi: 10.1007/s00401-017-1788-5. Epub 2017 Nov 18.

Botulinum Toxin Type A Injections as Monotherapy for Upper Limb Essential Tremor Using Kinematics

Samotus O, Kumar N, Rizek P, Jog M.

Can J Neurol Sci. 2018 Jan;45(1):11-22. doi: 10.1017/cjn.2017.260. Epub 2017 Nov 21.

Efficacy and safety of perampanel in Parkinson's disease. A systematic review with meta-analysis

Lattanzi S, Grillo E, Brigo F, Silvestrini M.

J Neurol. 2018 Apr;265(4):733-740. doi: 10.1007/s00415-017-8681-y. Epub 2017 Nov 20.

Pulse duration settings in subthalamic stimulation for Parkinson's disease

Steigerwald F, Timmermann L, Kühn A, Schnitzler A, Reich MM, Kirsch AD, Barbe MT, Visser-Vandewalle V, Hübl J, van Riesen C, Groiss SJ, Moldovan AS, Lin S, Carcieri S, Manola L, Volkmann J.

Mov Disord. 2018 Jan;33(1):165-169. doi: 10.1002/mds.27238. Epub 2017 Nov 22.

Global scales for cognitive screening in Parkinson's disease: Critique and recommendations

Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P; members of the MDS Rating Scales Review Committee.

Mov Disord. 2018 Feb;33(2):208-218. doi: 10.1002/mds.27233. Epub 2017 Nov 23.

Levodopa: A new look at an old friend

Olanow CW, Stocchi F.

Mov Disord. 2018 Jul;33(6):859-866. doi: 10.1002/mds.27216. Epub 2017 Nov 27.

Complex Dynamics in the Basal Ganglia: Health and Disease Beyond the Motor System

Andres DS, Darbin O.

J Neuropsychiatry Clin Neurosci. 2018 Spring;30(2):101-114. doi: 10.1176/appi.neuropsych.17020039. Epub 2017 Nov 29.

Rare case of atypical parkinsonism: why family history is important

Malek N, Jampana R, Grosset DG.

Scott Med J. 2017 Nov;62(4):159-162. doi: 10.1177/0036933017727966. Epub 2017 Dec 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias